Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome

被引：0
|
作者：
Gattorno, Marco [1 ]
Obici, Laura [2 ]
Meini, Antonella
Tormey, Vincent [3 ]
Abrams, Ken [4 ]
Davis, Nicole [4 ]
Andrews, Christopher [5 ]
Lachmann, Helen J. [6 ]
机构：
[1] Ist Giannina Gaslini, I-16148 Genoa, Italy
[2] IRCCS Policlin San Matteo, Pavia, Italy
[3] Galway Univ Hosp, Galway, Ireland
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharmaceut UK Ltd, Surrey, England
[6] UCL, Sch Med, London W1N 8AA, England
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
749
引用
收藏
页码：S322 / S322
页数：1
相关论文
共 50 条
  • [21] Anakinra for the treatment of TNF receptor associated periodic syndrome
    Gomes, Melo S.
    Loeffler, J.
    Rowczenio, D.
    Trojer, H.
    Russell, T.
    Drewe, E.
    McDermott, E.
    Rannigan, L.
    Lane, T.
    Woo, P.
    Brogan, P.
    Hawkins, P. N.
    Lachmann, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 462 - 462
  • [22] Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience
    Russo, Ricardo A. G.
    Melo-Gomes, Sonia
    Lachmann, Helen J.
    Wynne, Karen
    Rajput, Kaukab
    Eleftheriou, Despina
    Edelsten, Clive
    Hawkins, Philip N.
    Brogan, Paul A.
    RHEUMATOLOGY, 2014, 53 (04) : 665 - 670
  • [23] Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger
    Brogan, Paul A.
    Hofer, Michael
    Kuemmerle-Deschner, Jasmin B.
    Kone-Paut, Isabelle
    Roesler, Joachim
    Kallinich, Tilmann
    Horneff, Gerd
    Calvo Penades, Inmaculada
    Sevilla-Perez, Belen
    Goffin, Laurence
    Lauwerys, Bernard R.
    Lachmann, Helen J.
    Uziel, Yosef
    Wei, Xiaoling
    Laxer, Ronald M.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1955 - 1963
  • [24] Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
    Gattorno, Marco
    Obici, Laura
    Cattalini, Marco
    Tormey, Vincent
    Abrams, Ken
    Davis, Nicole
    Speziale, Antonio
    Bhansali, Suraj G.
    Martini, Alberto
    Lachmann, Helen J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) : 173 - 178
  • [25] Canakinumab Use in Patients with Cryopyrin-Associated Periodic Syndrome: Interim Safety and Efficacy Results from Beta-Confident Registry.
    Hoffman, Hal M.
    Kuemmerle-Deschner, Jasmin B.
    Hawkins, Philip N.
    van der Poll, T.
    Walker, Ulrich A.
    Abrams, Ken
    Tilson, Hugh H.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S367 - S367
  • [26] Understanding the Molecular Pathogenesis of and Response to Canakinumab Treatment in TNF Receptor-Associated Periodic Syndrome By Gene Expression Profiling of Whole Blood from Patients
    Torene, R.
    Gattorno, M.
    Lachmann, H.
    Obici, L.
    Meini, A.
    Tormey, V.
    Caorsi, R.
    Baeriswyl, L.
    Affentranger, U.
    Starck-Schwertz, S.
    Letzkus, M.
    Hartmann, N.
    Abrams, K.
    Nirmala, N.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S130 - S131
  • [27] Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China
    Zhu, Xiaona
    Fan, Jiaqi
    Huang, Yanyan
    Xu, Yongbin
    Yang, Zhi
    Weng, Ruohang
    Luo, Ying
    Yang, Jun
    He, Tingyan
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [28] Long-term Efficacy and Safety of Canakinumab in Active Hyperimmunoglobulinemia D with Periodic Fever Syndrome
    Ignacio Arostegui, Juan
    Anton, Jordi
    Calvo-Penedes, Inmaculada
    Robles, Angel
    Speziale, Antonio
    Joubert, Yolandi
    Lunge, Guido
    Yague, Jordi
    PEDIATRICS, 2018, 141
  • [29] Long-Term Efficacy and Safety of Canakinumab in Active Hyperimmunoglobulinemia D with Periodic Fever Syndrome
    Ignacio Arostegui, Juan
    Anton, Jordi
    Calvo-Penedes, Inmaculada
    Robles, Angel
    Speziale, Antonio
    Joubert, Yolandi
    Junge, Guido
    Yaguee, Jordi
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [30] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
    Kuemmerle-Deschner J.
    Hoffman H.
    Hawkins P.N.
    van der Poll T.
    Walker U.A.
    Speziale A.
    Tilson H.H.
    Pediatric Rheumatology, 13 (Suppl 1)
12345